Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ADAM12 |
| Upstream (Parents) |
|---|
| (<<) ANTXR1 → ADAM12 |
| (<<) ANTXR2 → ADAM12 |
| (<<) CDH11 → ADAM12 |
| (<<) CXCR7 → ADAM12 |
| (<<) EDNRA → ADAM12 |
| (<<) ELK3 → ADAM12 |
| (<<) INHBA → ADAM12 |
| (<<) ITGAV → ADAM12 |
| (<<) ITGB5 → ADAM12 |
| (<<) MXRA8 → ADAM12 |
| (<<) NBL1 → ADAM12 |
| (<<) PCDH7 → ADAM12 |
| (<<) PLAT → ADAM12 |
| (<<) RECK → ADAM12 |
| (<<) SULF1 → ADAM12 |
| (<<) TIMP2 → ADAM12 |
| (<<) UBE2C → ADAM12 |
| (<<) VEGFC → ADAM12 |
| Downstream (Children) |
|---|
| ADAM12 → ACTA2 (>>) |
| ADAM12 → ARSI (>>) |
| ADAM12 → CBS (>>) |
| ADAM12 → CNIH4 (>>) |
| ADAM12 → COL13A1 (>>) |
| ADAM12 → DEPDC7 (>>) |
| ADAM12 → DNM2 (>>) |
| ADAM12 → E2F5 (>>) |
| ADAM12 → FZD2 (>>) |
| ADAM12 → GNG11 (>>) |
| ADAM12 → GULP1 (>>) |
| ADAM12 → HOPX (>>) |
| ADAM12 → HOXA3 (>>) |
| ADAM12 → IGFBP3 (>>) |
| ADAM12 → IGFBP7 (>>) |
| ADAM12 → KLF7 (>>) |
| ADAM12 → MEGF6 (>>) |
| ADAM12 → MMP28 (>>) |
| ADAM12 → MMP3 (>>) |
| ADAM12 → MN1 (>>) |
| ADAM12 → MYLK (>>) |
| ADAM12 → NEDD4 (>>) |
| ADAM12 → NFATC4 (>>) |
| ADAM12 → ODC1 (>>) |
| ADAM12 → ODZ2 (>>) |
| ADAM12 → PAK2 (>>) |
| ADAM12 → PDGFB (>>) |
| ADAM12 → PELO (>>) |
| ADAM12 → PLA2R1 (>>) |
| ADAM12 → PRKCDBP (>>) |
| ADAM12 → RORA (>>) |
| ADAM12 → SCG5 (>>) |
